Welcome to the EAASM website  

Contact us at enquiries@eaasm.eu to share your experiences of buying medicines online, or receiving medicines from your pharmacist which have seemed out of the ordinary.

The European Alliance for Access to Safe Medicines (EAASM) is an independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines. The Alliance was formed by a cross-section of European stake-holders from a variety of backgrounds. Its key activities include campaigning for the safer use of unlicensed or off-label medicines and also the exclusion of counterfeit and substandard medicines from the supply chain, raising public awareness around such issues, and promoting effective legislation and enforcement in relation to falsified medicines. For a leaflet summarising the EAASM's activities and achievements click here

On this website you will find a wealth of information about counterfeit and substandard medicines. Our top tips section will help you to reassure yourself that the prescription medicine you are buying is genuine. Our news section will provide you with the latest news on counterfeit medicines in Europe and around the world as well as updates about the EAASM activities. The EAASM constantly updates and adds useful resources to the website so you can get as much information as possible about obtaining safe medicines.

Latest News

Roundtable “Improving patient safety with the FMD in the hospital pharmacy, status of implementation” 19 February 2019, EU Parliament

22 Feb 2019

The manufacture and distribution of falsified medicines has become an enormous, serious public health risk with an untold cost to lives.

On 9 February 2019, almost 7 years after its adoption, the final elements of the Falsified Medicines Directive (FMD) came into force introducing the end-to-end verification and safety features on prescription medicines across all Member States, representing a major advance to in patient safety due to the enhanced security of medicines in the supply chain.

 

Roundtable discussion “Improving patient safety with the FMD in the hospital pharmacy, status of implementation” – 19 February 2019

25 Jan 2019

The manufacture and distribution of falsified medicines is a growing public health risk with an untold cost to lives. The implementation on February 9th 2019 of the safety features of the Falsified Medicines Directive (FMD) will be a major advance and will greatly help to protect patients from falsified medicines.

EAASM addresses The British Medical Journal and Royal College of Physicians Annual Global Conference

7 Dec 2018

Mike Isles, Executive Director of ASOP EU and the EAASM, addressed doctors at the Global Health Horizons – “Learning from the past, looking in to the future” symposium held at the Royal College of Physicians, in London.